Stock ZVSA ZYVERSA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. ZyVersa Therapeutics, Inc.

Equities

ZVSA

US98987D3008

Market Closed - Nasdaq
Other stock markets
 21:30:01 28/05/2024 BST 		5-day change 1st Jan Change
4.254 USD -1.31% Intraday chart for ZyVersa Therapeutics, Inc. -3.33% -52.74%
03-25 ZyVersa Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-18 ZyVersa Therapeutics, Inc. Announces IRB Approval of Phase 2A Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator VAR 200 in Patients with Diabetic Kidney Disease CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Cuts Price Target on ZyVersa Therapeutics to $12 From $24, Maintains Buy Rating
MT
Wall Street Set to Open Flat Friday as Investors Remain Wary of Potential Interest Rate Hike
MT
HC Wainwright Starts ZyVersa Therapeutics With Buy Rating, Price Target is $2.50
MT
ZyVersa Therapeutics, Inc. Announces Article Published in Metabolism Pointing to Glomerular Cholesterol Accumulation as Key Factor Exacerbating Renal Injury and Dysfunction in Diabetic Kidney Disease
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZVSA Stock
  4. News ZyVersa Therapeutics, Inc.
  5. Analyst Reco.